» Articles » PMID: 34796770

The Role of Directional Atherectomy in Critical-limb Ischemia

Overview
Publisher Sage Publications
Date 2021 Nov 19
PMID 34796770
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Our aim was to review the current literature of the use of directional atherectomy (DA) in the treatment of lower extremity critical-limb ischemia.

Methods: A search for relevant literature was performed in PubMed and PubMed Central on 16 April 2020, sorted by best match. Three searches across two databases were performed. Articles were included that contained clinical and procedural data of DA interventions in lower extremity critical-limb ischemia patients. All studies that were systematic reviews were excluded.

Results: Eleven papers were included in this review. Papers were examined under several parameters: primary patency and secondary patency, limb salvage/amputation, technical/procedural success, complications/periprocedural events, and mean lesion length. Primary and secondary patency rates ranged from 56.3% to 95.0% and 76.4% to 100%, respectively. Limb salvage rates ranged from 69% to 100%. Lesion lengths were highly varied, representing a broad population, ranging from 30 ± 33 mm to 142.4 ± 107.9 mm.

Conclusions: DA may be a useful tool in the treatment of lower extremity critical-limb ischemia.

Citing Articles

First-in-Man Study of a Novel Peripheral Plaque Atherectomy Device.

Wang H, Pan D, Cui S, Tong Z, Gao X, Gu Y J Clin Hypertens (Greenwich). 2025; 27(1):e14967.

PMID: 39854100 PMC: 11771806. DOI: 10.1111/jch.14967.


Directional atherectomy for retained valves in a femoropopliteal saphenous vein bypass graft.

Subramanian T, Weiss R, Lee C J Vasc Surg Cases Innov Tech. 2024; 10(2):101406.

PMID: 38379615 PMC: 10877165. DOI: 10.1016/j.jvscit.2023.101406.

References
1.
Schulte K, Pilger E, Schellong S, Ten Tan K, Baumann F, Langhoff R . Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study). J Endovasc Ther. 2015; 22(5):690-7. DOI: 10.1177/1526602815598955. View

2.
Rastan A, Brechtel K, Krankenberg H, Zahorsky R, Tepe G, Noory E . Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012; 60(7):587-91. DOI: 10.1016/j.jacc.2012.04.035. View

3.
Semaan E, Hamburg N, Nasr W, Shaw P, Eberhardt R, Woodson J . Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty. Vasc Endovascular Surg. 2009; 44(1):25-31. PMC: 4429911. DOI: 10.1177/1538574409345028. View

4.
Cioppa A, Stabile E, Popusoi G, Salemme L, Cota L, Pucciarelli A . Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. Cardiovasc Revasc Med. 2012; 13(4):219-23. DOI: 10.1016/j.carrev.2012.04.007. View

5.
Scheinert D, Katsanos K, Zeller T, Koppensteiner R, Commeau P, Bosiers M . A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol. 2012; 60(22):2290-5. DOI: 10.1016/j.jacc.2012.08.989. View